Novan CEO Stasko’s total compensation increases 280 percent
Acne drug maker Novan Inc. paid Chief Executive Officer Nathan Stasko $1.98 million in compensation in 2016, a 280 percent increase from $520,000 in 2015, according to a filing with the Securities and Exchange Commission. Stasko’s base salary increased 5.9 percent between the two years. The compensation increase in pay primarily came from $1.4 million in options awards associated with Stasko’s performance in fiscal 2015. Stasko owns 5.7 percent of the company’s stock, worth $5 million based on Tuesday’s share price. He also holds stock options worth another $353,000, including 30,000 shares at an exercise price of $1.12 and 33,333 shares at...
Read More